Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Become EABM
Become Reviewer



Meet Our Editorial Board Member free to download

Volume:17   Issue: 2
Pp: 99-99
William Cho
DOI: 10.2174/156800961702170109213433



Anticancer Potential and Molecular Targets of Pristimerin: A Mini- Review

Volume:17   Issue: 2
Pp: 100-108
Bashir A. Yousef, Hozeifa M. Hassan, Lu-Yong Zhang and Zhen-Zhou Jiang
DOI: 10.2174/1568009616666160112105824




Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors

Volume:17   Issue: 2
Pp: 109-121
Alessandro Federico, Silvia Zappavigna, Marcello Dallio, Gabriella Misso, Francesco Merlino, Carmela Loguercio, Ettore Novellino, Paolo Grieco and Michele Caraglia
DOI: 10.2174/1568009616666160621101248




Current Development of ROS-Modulating Agents as Novel Antitumor Therapy

Volume:17   Issue: 2
Pp: 122-136
Nan Wang, Yue Wu, Jinlei Bian, Xue Qian, Hongzhi Lin, Haopeng Sun, Qidong You and Xiaojin Zhang
DOI: 10.2174/1568009616666160216125833




Targeting Key Metabolic Enzymes Involved in Lipid and Protein Biosyntheses for Breast Anticancer Therapies

Volume:17   Issue: 2
Pp: 158-168
Mounia Guerram, Aida Mejda Hamdi, Lu-Yong Zhang and Zhenzhou Jiang
DOI: 10.2174/1568009616666160603123014




Pax5 Re-expression in H460 Cells Treated with the Combination of Demethylating Agent and Histone Deacetylase Inhibitor is Associated with the Enhancement of P53 Binding to Pax5 Promoter Region

Volume:17   Issue: 2
Pp: 169-176
Yuanxin Liang, Jinwu Zeng, Linda Jelicks, Shengwei Ma, Jing Liu, Jingsong Mei, Roman Perez-Soler and Yiyu Zou
DOI: 10.2174/1568009616666160331124759



CYR61 Confers the Sensitivity to Aromatase Inhibitor Letrozole in ER Positive Breast Carcinoma

Volume:17   Issue: 2
Pp: 191-197
Xiaoqing Jia, Guangyu Liu, Jingyi Cheng, Zhenzhou Shen and Zhimin Shao
DOI: 10.2174/1568009616666160426125058